Fischer Medical Ventures Ltd
FISCHERFischer Medical Ventures Ltd
FISCHER
Price Chart
Scorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 1,717.88 | 42.36 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 23.30 | 3.52 | 1.25% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Fischer Medical Ventures Limited is primarily involved in trading laboratory chemicals and machinery. The company focuses on providing essential supplies for laboratory operations.
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2023 | FY 2024 | TTM | |||
|---|---|---|---|---|---|---|
| Total Revenue | 0.18 | 21.48 | 72.22 | |||
Raw Materials | 0.00 | 0.08 | 68.83 | |||
| Power & Fuel Cost | 0.00 | 0.19 | ||||
| Employee Cost | 0.05 | 0.38 | ||||
| Selling & Administrative Expenses | 0.11 | 1.84 | ||||
| Operating & Other expenses | 0.00 | 16.64 | ||||
EBITDA | 0.02 | 2.35 | 3.39 | |||
| Depreciation/Amortization | 0.00 | 0.18 | 0.75 | |||
| PBIT | 0.02 | 2.17 | 2.64 | |||
| Interest & Other Items | 0.02 | 0.07 | 0.25 | |||
| PBT | 0.00 | 2.10 | 2.39 | |||
| Taxes & Other Items | 0.04 | 0.27 | 0.39 | |||
| Net Income | -0.04 | 1.83 | 2.00 | |||
| EPS | -2.33 | 0.68 | 0.37 | |||
| DPS | 0.00 | 0.00 | 0.00 | |||
| Payout ratio | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
UtilitiesPower Trading & Consultancy
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Fischer Medical Ventures Ltd | 1,877.47 | 42.36 | — |
| Indian Energy Exchange Ltd | 47.18 | 17.03 | 1.34% |
| Rattanindia Enterprises Ltd | 23.55 | 11.87 | — |
| PTC India Ltd | 10.97 | 0.87 | 4.41% |
Price Comparison
Compare FISCHER with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Mar 2024
May 2024
Jun 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
FISCHER has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNet profit of Fischer Medical Ventures rose 264.29% to Rs 0.51 crore in the quarter ended September 2024 as against Rs 0.14 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 as against Rs 0.19 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales00.19 -100 OPM %073.68 - PBDT0.460.15 207 PBT0.460.15 207 NP0.510.14 264 Powered by Capital Market - Live
The Board of Fischer Medical Ventures at its meeting held on 13 November 2024 has approved the appointment of Vivek Balasubramanian as the Chief Financial Officer of the Company with effect from 13 November 2024. The Board accepted the resignation of Dilip Suryakant Jha who resigned as Chief Financial Officer of the Company with effect from 12 November 2024. Powered by Capital Market - Live
Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
Fischer Medical Ventures announced that the 31th Annual General Meeting (AGM) of the company will be held on 17 September 2024.Powered by Capital Market - Live
Net profit of Fischer Medical Ventures reported to Rs 0.84 crore in the quarter ended June 2024 as against net loss of Rs 0.22 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live
Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
Fischer Chemic reports standalone net loss of Rs 0.07 crore in the September 2021 quarter
Fischer Chemic reports standalone net loss of Rs 0.05 crore in the June 2021 quarter
Fischer Chemic reports standalone net loss of Rs 0.02 crore in the March 2021 quarter
Increased Total Promoter Holding
In last 6 months, promoter holding in the company has increased by 74.91%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant